Infezione e infiammazione. Effetti di nuove molecole antimicrobiche sull’omeostasi di cellule articolari e caratterizzazione dell’infiltrato cellulare periprotesico nella flogosi settica

Title

Code

AMP-PJI

Type

Sperimentale

Start Year

2023

Status

In Corso

Principal Investigator

051-6366093

paolo.dolzani@ior.it

Dolzani Paolo, MSc

Biologist

Laboratory of Immunorheumatology and tissue regeneration

Operational unit that carry out the study

complex unit

Laboratorio di Immunoreumatologia e rigenerazione tissutale

Temporary Director

Arciola Carla Renata, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. AMP-PJI

Monday 9 October 2023, 14:58

PG0014579_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Infezione e infiammazione. Effetti di nuove molecole antimicrobiche sull’omeostasi di cellule articolari e caratterizzazione dell’infiltrato cellulare periprotesico nella flogosi settica

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in